Tanus-Santos JE - Search Results

1

Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6.

Desai M, Tanus-Santos JE, Li L, Gorski JC, Arefayene M, Liu Y, Desta Z, Flockhart DA. Desai M, et al. Pharmacogenomics J. 2003;3(2):105-13. doi: 10.1038/sj.tpj.6500160. Pharmacogenomics J. 2003. PMID: 12746736 Clinical Trial.

2

Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants.

Tanus-Santos JE, Desai M, Flockhart DA. Tanus-Santos JE, et al. Pharmacogenetics. 2001 Nov;11(8):719-25. doi: 10.1097/00008571-200111000-00011. Pharmacogenetics. 2001. PMID: 11692081

3

Implications of cytochrome P450 interactions when prescribing medication for hypertension.

Flockhart DA, Tanus-Santos JE. Flockhart DA, et al. Arch Intern Med. 2002 Feb 25;162(4):405-12. doi: 10.1001/archinte.162.4.405. Arch Intern Med. 2002. PMID: 11863472 Review.

4

Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol.

Tanus-Santos JE, Desai M, Deak LR, Pezzullo JC, Abernethy DR, Flockhart DA, Freedman JE. Tanus-Santos JE, et al. Pharmacogenetics. 2002 Jul;12(5):407-13. doi: 10.1097/00008571-200207000-00008. Pharmacogenetics. 2002. PMID: 12142730

5

Sequence diversity and functional characterization of the 5'-regulatory region of human CYP2C19.

Arefayene M, Skaar TC, Zhao X, Rae JM, Tanus-Santos JE, Brinkmann U, Brehm I, Salat U, Nguyen A, Desta Z, Flockhart DA. Arefayene M, et al. Pharmacogenetics. 2003 Apr;13(4):199-206. doi: 10.1097/00008571-200304000-00004. Pharmacogenetics. 2003. PMID: 12668916

6

Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men.

Metzger IF, Souza-Costa DC, Marroni AS, Nagassaki S, Desta Z, Flockhart DA, Tanus-Santos JE. Metzger IF, et al. Pharmacogenet Genomics. 2005 Aug;15(8):565-70. doi: 10.1097/01.fpc.0000167328.85163.44. Pharmacogenet Genomics. 2005. PMID: 16007000

7

Endothelial nitric oxide synthase haplotypes are related to blood pressure elevation, but not to resistance to antihypertensive drug therapy.

Sandrim VC, Yugar-Toledo JC, Desta Z, Flockhart DA, Moreno H Jr, Tanus-Santos JE. Sandrim VC, et al. J Hypertens. 2006 Dec;24(12):2393-7. doi: 10.1097/01.hjh.0000251899.47626.4f. J Hypertens. 2006. PMID: 17082721

8

Assessment of vascular effects of tamoxifen and its metabolites on the rat perfused hindquarter vascular bed.

Montenegro MF, Pessa LR, Gomes VA, Desta Z, Flockhart DA, Tanus-Santos JE. Montenegro MF, et al. Basic Clin Pharmacol Toxicol. 2009 May;104(5):400-7. doi: 10.1111/j.1742-7843.2009.00377.x. Basic Clin Pharmacol Toxicol. 2009. PMID: 19413660 Free article.

9

Tamoxifen and its metabolites cause acute vasorelaxation of aortic rings by inducing vasodilator prostanoid synthesis.

Montenegro MF, Ceron CS, Salgado MC, Desta Z, Flockhart DA, Tanus-Santos JE. Montenegro MF, et al. J Cardiovasc Pharmacol. 2011 Dec;58(6):647-53. doi: 10.1097/FJC.0b013e31823171ba. J Cardiovasc Pharmacol. 2011. PMID: 21885992

10

Endothelial nitric oxide synthase genotypes and haplotypes modify the responses to sildenafil in patients with erectile dysfunction.

Muniz JJ, Lacchini R, Rinaldi TO, Nobre YT, Cologna AJ, Martins AC, Tanus-Santos JE. Muniz JJ, et al. Pharmacogenomics J. 2013 Apr;13(2):189-96. doi: 10.1038/tpj.2011.49. Epub 2011 Nov 8. Pharmacogenomics J. 2013. PMID: 22064666

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

418 results

Search Page

Filters